CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
unknown
戊型肝炎病毒颗粒性蛋白疫苗H-2~d限制性Th表位的筛选
Authors
伍小路
吴婷
+6 more
夏宁邵
张军
李少伟
林春鑫
欧山海
程通
Publication date
30 May 2006
Publisher
Abstract
戊型肝炎病毒衣壳蛋白重组抗原HEV 239能形成类病毒颗粒,具备演变成多价疫苗的载体的潜力,此文旨在筛选、鉴定其内包含的H-2d限制性Th表位。以50μg HEV 239蛋白与完全弗式佐剂混合后皮下免疫BALB/c鼠,以覆盖HEV 239蛋白全长的15氨基酸肽库体外刺激其脾细胞,用IFN--γELISPOT方法检测其细胞免疫应答,并通过磁珠剔除脾细胞中CD4+T细胞或CD8+T细胞以分析筛选得到的T细胞表位的特性。结果显示:HEV 239中包含优势的T细胞表位P34(HEV PORF2 AA533~AA547,HSKTF FVLPL RGKLS)及数个较弱的T细胞表位,P34对HEV 239免疫的BALB/c鼠脾细胞的刺激效果与HEV 239蛋白相当,剔除实验表明该表位为CD4+T细胞表位,即Th表位
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Xiamen University Institutional Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dspace.xmu.edu.cn:2288/211...
Last time updated on 16/06/2016